ArticleJournal of cancer research and clinical oncology2011

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma.

Katharina Pachmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.